Riamet 20 mg/120 mg, Tabletten

7680545940387 CH-54594 Tabletten

Associated product:

RIAMET cpr 20 mg/120 mg 24 pce
Riamet 20 mg/120 mg, Tabletten
Riamet 20 mg/120 mg, Tabletten
Riamet 20 mg/120 mg, Tabletten
1 / 3
google

Article details

Package size
24
Selling units
24
Measure
Tablette(n)
Galenic form
Tabletten
Galenic group
Tabletten

Official Swissmedic V2 data

Additional information from the official database

Official medical documents

Patient information leaflet
Allemand
21/09/2020
Patient information leaflet
Français
21/09/2020
Patient information leaflet
Italien
21/09/2020
Summary of Product Characteristics
Allemand
21/09/2020
Summary of Product Characteristics
Français
21/09/2020
Summary of Product Characteristics
Italien
21/09/2020

Detailed composition

Substance Quantity Type Category
(N/A)
20.0 MG Substance Wirkstoff (Principe actif)
(N/A)
120.0 MG Substance Wirkstoff (Principe actif)
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
2.3 MG Substance HBESI
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK

Reimbursement information

Public price
CHF 44.65
Specialties list
Yes
Generic
No

Reimbursement limitation

SL addition date: 15/03/1999

Authorization holder

Novartis Pharma Schweiz AG

6343 Risch

Authorization information

Swissmedic authorization number
54594
Drug name
Riamet, Tabletten
Galenic form
TAB
ATC Code
P01BF01
Authorization status
Z
Dispensing category
A
First authorization
22/01/1999
Authorization expiration date
31/12/9999
IT Number
08.04.1.
Domain
Human medicine
Field of application
Malaria

Package details

Description (FR)
RIAMET cpr 20 mg/120 mg 24 pce
Description (DE)
RIAMET Tabl 20 mg/120 mg 24 Stk
Market launch
22/01/1999
Narcotic (BTM)
No

Other package sizes (1)

None
None None
GTIN: None
Not in V1